To further validate this finding, western blotting was performed showing that HOXD13 overexpression significantly increased, while silencing of HOXD13 decreased the expression of stem cell marker proteins in glioma cells (Figure 5F). This evidence concerns the gene HOXD13 and central nervous system cancer.